You must enable cookies for this web site to function properly.
Every year, more than 14,000 patients are diagnosed with life-threatening blood cancers—like leukemia and lymphoma—or other diseases for which a stem cell transplant may be their best or only hope of a cure. The authority for the programs that support these patients expired September 30. The House has passed a reauthorization bill (H.R. 2820), so it is now up to the Senate to ensure that both programs are reauthorized.
Dear [Decision Maker],
Sincerely,[Your Name] [Your Address] [City, State ZIP]